procurement of drugs and materials ( limited ) -2 amikacin ( 500mg / 2ml ( 2ml vial ) ) , injection 3 amoxycilline ( 500mg ) , capsule 4 cefixime ( 200 mg tab ( dt tablet also acceptable ) ) , tablet 5 halothane bp 250ml 6 methyldopa tab. - 250mg 7 ringer lactate ip i / v 0.24 % w / v of lactic acid ( eq. to 0.32% w / v of sodium lactate ) , 0.6 % w / v sodium chloride, 0.04 % w / v potassium chloride and 0.027 % w / v calcium chloride ( 500ml ffs bottle ) , infusion 8 albendazole ip ( 400mg ) , tablet 9 ferrous ascorbate 100mg ( elemental iron ) +folic acid 1.5mg ( tablet ) , tablet 10 calcium with vitamin d tablets usp calcium carbonate 1.25g eq. to elemental ( calcium 500mg and cholecalciferol ip 250 iu ) , tablet 11 iron folic acid sugar coated ( red tablet ) ferrous sulphate ip equivalent to 60 mg elemental iron & 500 mcg folic acid ip ( 60 mg + 500 mcg ) , tablet 12 folic acid tab ( 400 mcg ) , tablet 13 amlodipin tab ( 5mg ) , tablet 14 cefotaxime sodium ( 1 gm vial ) , injection 15 ciprofloxacin eye ointment 0.3% ( 3gm tube ) 16 insulin soluble inj. - 40 iu / ml 17 ranitidine ( 50mg / 2ml , 2ml amp ) , injection 18 silver sulphadiazine cream ( usp 1% w / w 25gm ) , tube 19 telmisartan ( 40 mg ) , tablet 20 charcoal activated ( powder ) ( 100 gm box / pouch ) , oral powder 21 cefixime ( 50 mg dt ) , tablet 22 dexamethasone ( 0.5mg ) , tablet [ 110038 ] 23 atorvastatin ( ip 10 mg ) , tablet [ 110238 ] => limited